Amisulpride - Generic Drug Details
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for amisulpride and what is the scope of freedom to operate?
Amisulprideis the generic ingredient in one branded drug marketed by Acacia and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Amisulpride has sixty-five patent family members in twenty-six countries.
There are four drug master file entries for amisulpride. One supplier is listed for this compound.
Summary for amisulpride
|Drug Master File Entries:||4|
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||132|
|What excipients (inactive ingredients) are in amisulpride?||amisulpride excipients list|
|DailyMed Link:||amisulpride at DailyMed|
Recent Clinical Trials for amisulpride
Identify potential brand extensions & 505(b)(2) entrants
|Amicus CD LLC||Phase 2/Phase 3|
|Acacia Pharma Ltd||Phase 2/Phase 3|
|Premier Research Group plc||Phase 2/Phase 3|
Pharmacology for amisulpride
|Drug Class||Dopamine-2 Receptor Antagonist|
|Mechanism of Action||Dopamine D2 Antagonists|
Anatomical Therapeutic Chemical (ATC) Classes for amisulpride
US Patents and Regulatory Information for amisulpride
International Patents for amisulpride
|Country||Patent Number||Title||Estimated Expiration|
|Hungary||E037088||See Plans and Pricing|
|Hong Kong||1179152||氨磺必利用於製備治療噁心、嘔吐和反胃的病症的藥劑的用途 (THE USE OF AMISULPRIDE FOR PRODUCING AN AGENT IN THE THERAPY OF NAUSEA, VOMITING AND RETCHES)||See Plans and Pricing|
|Serbia||57032||UPOTREBA AMISULPRIDA ZA TRETIRANJE OPIJATOM INDUKOVANE MUČNINE I POVRAĆANJA (USE OF AMISULPRIDE FOR TREATING OPIATED-INDUCED NAUSEA AND VOMITING)||See Plans and Pricing|
|Croatia||P20140745||See Plans and Pricing|
|European Patent Office||2796171||Utilisation de l'amisulpride pour le traitement des nausées et vomissements induits par les opiacés (Use of amisulpride for treating opiated-induced nausea and vomiting)||See Plans and Pricing|
|Japan||2020506209||術後悪心嘔吐の救急治療||See Plans and Pricing|
|Spain||2496099||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.